Orbits Oncology
PrivateLast Round
Accelerator
Feb 27, 2025
Total Funding Raised
$250,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Orbits Oncology is a biotechnology company that develops a cloud-based, AI-powered image analysis and drug screening platform designed to help cancer researchers make decisions in drug development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Precision Medicine, Medical AI, Medical Imaging, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orbits Oncology Comparables
Compare Orbits Oncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ProxyBio | 82% | |
| QuantaCell | 78% | |
| Orakl Oncology | 70% | |
Orbits Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Feb 27, 2025 | ||||
| Accelerator | Aug 6, 2024 |
Key People
Founding team and executive leadership
Orbits Oncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AlphaLab | Accelerator |
| Northpond Ventures | Accelerator |
| McKesson Ventures | Accelerator |
| Innovation Works | Accelerator |
| Merck Digital Sciences Studio | Accelerator |
| New Jersey Innovation Institute | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 96% MoM.
- May 17, 2026
Monthly visitors increased 267% MoM.
Orbits Oncology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Orbits Oncology's valuation, stock price, and market status.